FDA Approves New Prostate Cancer Imaging Agent Gozellix®

Go back to FDA Approves New Prostate Cancer Imaging Agent Gozellix®
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.62 --0 (-0%)
Previous Close $11.62    52 Week High $2.18 
Open $11.62    52 Week Low $0.30 
Day High $11.62    P/E N/A 
Day Low $11.62    EPS $-3.32 
Volume 10       

TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.62 --0 (-0%)
Previous Close $11.62    52 Week High $2.18 
Open $11.62    52 Week Low $0.30 
Day High $11.62    P/E N/A 
Day Low $11.62    EPS $-3.32 
Volume 10